Antibody Drug Development News

Antibody drug discovery and development is the process of identifying new therapeutic antibodies to combat different diseases such as cancers, HIV, autoimmune, hereditary, and more.

EGFRvIII specific CAR-NK cells for Glioblastoma

Induced pluripotent stem cells - How they are produced and how we use them

Developing Bispecific Antibodies: Introducing GenScript’s Proprietary SMAB Platform for Therapeutic Antibody Discovery

CAR T-Cell Therapies with a Bispecific Twist

CAR-T cell become

The clinical success of CAR-T therapy has make it as a major high potential cancer therapy approach.

Quick and economical method of determining the specificity of antibody drug lead and target-binding moiety for the target

Myeloid cells, such as tumor-associated macrophages (TAM) and polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC), comprise about 50% of the total tumor tissue weight.

Self and non-self recognition has always fascinated researchers in immunology, studying which is particularly useful for cancer immunotherapy as cancer cells often disguise themselves as “self” to evade immune attack.